P
Proniras
Developing therapies to help those fighting addiction
About Proniras
Proniras Corporation is a preclinical stage biotechnology company dedicated to the development of Tezampanel, a parenteral medical countermeasure (MCM) aimed at treating seizures and brain injuries caused by exposure to organophosphorus nerve agents. The company operates within the life sciences sector, focusing primarily on medical countermeasures for neurological conditions. Proniras serves governmental and defense agencies, as well as healthcare providers who require advanced treatments for nerve agent-induced conditions.
The business model revolves around research and development (R&D) funded through government contracts and grants. Proniras recently secured a significant contract worth up to $89.5 million from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to further develop Tezampanel. This funding supports their preclinical trials and eventual commercialization of the drug.
Revenue is generated through these government contracts and potential future sales of Tezampanel upon successful development and approval. The company aims to address a critical gap in medical countermeasures for nerve agent-induced seizures, positioning itself as a key player in this niche market.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- Seattle, United States
- Sector
- Biotech & Life Sciences
News
Open roles
Proniras in the Seattle ecosystem
The Proniras office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Accelerator Life Science Partners
Series A3 investors entered at this stage
ARCH Venture Partners
WRF Capital- WFWatson Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Proniras on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Proniras on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

